Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Michon

Showing results (91-100 of 108) with videos related to

Pageof 11
Sort By:
Journal of Pediatric Hematology/Oncology|January 5, 2012
Primary follicular lymphoma of the testis in children and adolescentsMark A Lones, Martine Raphael, Keith McCarthy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2014
Emergence of new ALK mutations at relapse of neuroblastomaGudrun Schleiermacher, Niloufar Javanmardi, Virginie Bernard, et al.
Pediatric Blood & Cancer|September 4, 2025
Atypical Neuroblastoma With Absent Urinary Catecholamine Excretion and <sup>123</sup>ImIBG Avidity Are of Favorable Outcome: A Retrospective French Single-Center StudyAnna Borovkov, Juliette Assy, Isabelle Aerts, et al.
International Journal of Cancer|April 25, 2019
Study of chromatin remodeling genes implicates SMARCA4 as a putative player in oncogenesis in neuroblastomaAngela Bellini, Nadia Bessoltane-Bentahar, Jaydutt Bhalshankar, et al.
Nature Genetics|February 14, 2012
Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcomaSophie Postel-Vinay, Amélie S Véron, Franck Tirode, et al.
The Lancet. Oncology|March 6, 2017
Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trialRuth Ladenstein, Ulrike Pötschger, Andrew D J Pearson, et al.
Acta Obstetricia Et Gynecologica Scandinavica|March 29, 2019
Ovarian tissue cryopreservation for fertility preservation in 418 girls and adolescents up to 15 years of age facing highly gonadotoxic treatment. Twenty years of experience at a single centerCatherine Poirot, Laurence Brugieres, Karima Yakouben, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2016
Genomic Copy Number Profiling Using Circulating Free Tumor DNA Highlights Heterogeneity in NeuroblastomaMathieu Chicard, Sandrine Boyault, Leo Colmet Daage, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Ewing Sarcoma: Current Management and Future Approaches Through CollaborationNathalie Gaspar, Douglas S Hawkins, Uta Dirksen, et al.
Cancer Discovery|September 17, 2014
Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutationsFranck Tirode, Didier Surdez, Xiaotu Ma, et al.
Pageof 11

Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
Journal of Pediatric Hematology/Oncology|January 5, 2012
Primary follicular lymphoma of the testis in children and adolescentsMark A Lones, Martine Raphael, Keith McCarthy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2014
Emergence of new ALK mutations at relapse of neuroblastomaGudrun Schleiermacher, Niloufar Javanmardi, Virginie Bernard, et al.
Pediatric Blood & Cancer|September 4, 2025
Atypical Neuroblastoma With Absent Urinary Catecholamine Excretion and <sup>123</sup>ImIBG Avidity Are of Favorable Outcome: A Retrospective French Single-Center StudyAnna Borovkov, Juliette Assy, Isabelle Aerts, et al.
International Journal of Cancer|April 25, 2019
Study of chromatin remodeling genes implicates SMARCA4 as a putative player in oncogenesis in neuroblastomaAngela Bellini, Nadia Bessoltane-Bentahar, Jaydutt Bhalshankar, et al.
Nature Genetics|February 14, 2012
Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcomaSophie Postel-Vinay, Amélie S Véron, Franck Tirode, et al.
The Lancet. Oncology|March 6, 2017
Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trialRuth Ladenstein, Ulrike Pötschger, Andrew D J Pearson, et al.
Acta Obstetricia Et Gynecologica Scandinavica|March 29, 2019
Ovarian tissue cryopreservation for fertility preservation in 418 girls and adolescents up to 15 years of age facing highly gonadotoxic treatment. Twenty years of experience at a single centerCatherine Poirot, Laurence Brugieres, Karima Yakouben, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2016
Genomic Copy Number Profiling Using Circulating Free Tumor DNA Highlights Heterogeneity in NeuroblastomaMathieu Chicard, Sandrine Boyault, Leo Colmet Daage, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Ewing Sarcoma: Current Management and Future Approaches Through CollaborationNathalie Gaspar, Douglas S Hawkins, Uta Dirksen, et al.
Cancer Discovery|September 17, 2014
Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutationsFranck Tirode, Didier Surdez, Xiaotu Ma, et al.
Pageof 11